Amalgamated Bank Johnson & Johnson Transaction History

Amalgamated Bank

$12.1 Billion
Q3 2024

A detailed history of Amalgamated Bank transactions in Johnson & Johnson stock. As of the latest transaction made, Amalgamated Bank holds 479,422 shares of JNJ stock, worth $69.9 Million. This represents 0.64% of its overall portfolio holdings.

Number of Shares

479,422

Previous 486,625 1.48%

Holding current value

$69.9 Million

Previous $71.1 Million 9.24%

% of portfolio

0.64%

Previous 0.61%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	SELL	$145.48 - $167.38 $1.05 Million - $1.21 Million	-7,203 Reduced 1.48%	479,422 $77.7 Million
Q2 2024 Aug 12, 2024	SELL	$144.38 - $157.78 $1.32 Million - $1.44 Million	-9,132 Reduced 1.84%	486,625 $71.1 Million
Q1 2024 Apr 23, 2024	SELL	$155.22 - $162.74 $12.8 Million - $13.5 Million	-82,742 Reduced 14.3%	495,757 $78.4 Million
Q4 2023 Feb 06, 2024	SELL	$145.6 - $158.88 $4.11 Million - $4.49 Million	-28,234 Reduced 4.65%	578,499 $90.7 Million
Q3 2023 Nov 08, 2023	SELL	$155.75 - $174.48 $9.33 Million - $10.5 Million	-59,935 Reduced 8.99%	606,733 $94.5 Million
Q2 2023 Aug 11, 2023	SELL	$154.35 - $166.11 $12.6 Million - $13.6 Million	-81,759 Reduced 10.92%	666,668 $110 Million
Q1 2023 May 02, 2023	BUY	$151.05 - $180.26 $9.86 Million - $11.8 Million	65,273 Added 9.55%	748,427 $116 Million
Q4 2022 Feb 10, 2023	SELL	$160.2 - $179.79 $7.75 Million - $8.69 Million	-48,351 Reduced 6.61%	683,154 $121 Million
Q3 2022 Nov 09, 2022	BUY	$161.33 - $179.52 $10.8 Million - $12 Million	66,753 Added 10.04%	731,505 $119 Million
Q2 2022 Aug 15, 2022	SELL	$168.19 - $186.01 $9.76 Million - $10.8 Million	-58,045 Reduced 8.03%	664,752 $118 Million
Q1 2022 Jun 30, 2022	SELL	$158.14 - $179.59 $7.01 Million - $7.97 Million	-44,356 Reduced 5.78%	722,797 $128 Million
Q4 2021 Feb 15, 2022	BUY	$155.93 - $173.01 $8.36 Million - $9.28 Million	53,639 Added 7.52%	767,153 $131 Million
Q3 2021 Oct 29, 2021	SELL	$161.5 - $179.47 $4.09 Million - $4.55 Million	-25,351 Reduced 3.43%	713,514 $115 Million
Q2 2021 Aug 16, 2021	BUY	$159.48 - $171.07 $94.5 Million - $101 Million	592,358 Added 404.32%	738,865 $122 Million
Q1 2021 May 13, 2021	SELL	$153.07 - $170.48 $867,447 - $966,110	-5,667 Reduced 3.72%	146,507 $24.1 Million
Q4 2020 Feb 12, 2021	SELL	$137.11 - $157.38 $59,505 - $68,302	-434 Reduced 0.28%	152,174 $23.9 Million
Q3 2020 Oct 30, 2020	SELL	$140.38 - $153.83 $477,713 - $523,483	-3,403 Reduced 2.18%	152,608 $22.7 Million
Q2 2020 Aug 10, 2020	SELL	$128.81 - $155.51 $31 Million - $37.4 Million	-240,676 Reduced 60.67%	156,011 $21.9 Million
Q1 2020 May 13, 2020	SELL	$111.14 - $153.99 $1.26 Million - $1.75 Million	-11,345 Reduced 2.78%	396,687 $52 Million
Q4 2019 Feb 13, 2020	BUY	$127.5 - $146.44 $3.02 Million - $3.46 Million	23,658 Added 6.15%	408,032 $59.5 Million
Q3 2019 Nov 13, 2019	BUY	$126.95 - $142.14 $867,322 - $971,100	6,832 Added 1.81%	384,374 $49.7 Million
Q2 2019 Aug 14, 2019	BUY	$131.15 - $144.24 $3.11 Million - $3.43 Million	23,748 Added 6.71%	377,542 $52.6 Million
Q1 2019 May 15, 2019	BUY	$125.72 - $139.79 $1.35 Million - $1.5 Million	10,721 Added 3.12%	353,794 $49.5 Million
Q4 2018 Feb 15, 2019	SELL	$122.84 - $147.84 $917,491 - $1.1 Million	-7,469 Reduced 2.13%	343,073 $44.3 Million
Q3 2018 Nov 14, 2018	SELL	$121.58 - $142.88 $1.06 Million - $1.24 Million	-8,678 Reduced 2.42%	350,542 $48.4 Million
Q2 2018 Jul 18, 2018	BUY	$119.4 - $131.76 $1.72 Million - $1.9 Million	14,392 Added 4.17%	359,220 $43.6 Million
Q1 2018 May 22, 2018	BUY	$125.1 - $148.14 $294,985 - $349,314	2,358 Added 0.69%	344,828 $44.2 Million
Q4 2017 Feb 13, 2018	BUY	$131.22 - $143.62 $3.99 Million - $4.37 Million	30,427 Added 9.75%	342,470 $47.9 Million
Q3 2017 Nov 09, 2017	BUY	$129.47 - $135.38 $40.4 Million - $42.2 Million	312,043	312,043 $40.6 Million

Others Institutions Holding JNJ

# of Institutions

4,275

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $381B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Account

Amalgamated Bank Johnson & Johnson Transaction History